Head and Neck Tumor Clinical Trials

4 recruiting

Head and Neck Tumor Trials at a Glance

12 actively recruiting trials for head and neck tumor are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Nanjing, Guangzhou, and Basking Ridge. Lead sponsors running head and neck tumor studies include Nanfang Hospital, Southern Medical University, Memorial Sloan Kettering Cancer Center, and Juergen Debus.

Browse head and neck tumor trials by phase

Treatments under study

About Head and Neck Tumor Clinical Trials

Looking for clinical trials for Head and Neck Tumor? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Head and Neck Tumor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Head and Neck Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 1

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Kidney CancersHead and Neck TumorsSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI)120 enrolled1 locationNCT06479811
Recruiting
Phase 3

Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma

Oropharynx CancerLarynx CancerHypopharynx Cancer+1 more
Centre Leon Berard460 enrolled8 locationsNCT06706401
Recruiting

Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors

Breast CancerPancreatic CancerSarcoma+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology26 enrolled1 locationNCT07552467
Recruiting
Not Applicable

Topical Diclofenac for Prevention of Radiation-induced Dermatitis

Breast CancerHead and Neck Tumor
The Second Affiliated Hospital of Hainan Medical University156 enrolled1 locationNCT06905561
Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Breast CancerLiver CancerEsophageal Cancer+35 more
UMC Utrecht8,000 enrolled18 locationsNCT04075305
Recruiting
Not Applicable

Multiparametric Imaging-based Intraoperative Navigation for Guidance of Surgical Resection and Postoperative Radiotherapy in Patients With Head-and-neck Tumors

Head and Neck Tumors
Juergen Debus60 enrolled1 locationNCT05671458
Recruiting
Not Applicable

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Ovarian CancerMelanomaHead and Neck Cancer+5 more
Memorial Sloan Kettering Cancer Center480 enrolled7 locationsNCT05053230
Recruiting
Phase 2

Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors

Head and Neck Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School29 enrolled1 locationNCT05758389
Recruiting

Correlation and Predictive Research of Metal Elements in Radiation-Induced Oral Mucositis

Head and Neck TumorsMetalCopper
Nanfang Hospital, Southern Medical University383 enrolled1 locationNCT06968520
Recruiting

99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

Pancreatic CancerLung CancerHead and Neck Tumor
Nanjing First Hospital, Nanjing Medical University20 enrolled1 locationNCT06438705
Recruiting

Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

Head and Neck Tumors
Regina Elena Cancer Institute18 enrolled1 locationNCT06791941
Recruiting

Breathomics in the Diagnosis and Prediction of Radiotherapy-Induced Oropharyngeal Mucositis in Head and Neck Tumors

Head and Neck TumorsVolatile Organic CompoundsBreathomics+1 more
Nanfang Hospital, Southern Medical University375 enrolled1 locationNCT06767488